NASDAQ:UG

United-Guardian Stock Forecast, Price & News

$15.45
-0.40 (-2.52 %)
(As of 07/29/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.45
$15.46
50-Day Range
$15.01
$17.90
52-Week Range
$13.41
$18.99
Volume797 shs
Average Volume7,189 shs
Market Capitalization$70.92 million
P/E Ratio19.07
Dividend Yield6.06%
Beta0.07
30 days | 90 days | 365 days | Advanced Chart
Receive UG News and Ratings via Email

Sign-up to receive the latest news and ratings for United-Guardian and its competitors with MarketBeat's FREE daily newsletter.


About United-Guardian

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. It also conducts research and development primarily related to the development of cosmetic ingredients. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.52 out of 5 stars

Medical Sector

933rd out of 2,216 stocks

Toilet Preparations Industry

7th out of 23 stocks

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











United-Guardian (NASDAQ:UG) Frequently Asked Questions

What stocks does MarketBeat like better than United-Guardian?

Wall Street analysts have given United-Guardian a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but United-Guardian wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is United-Guardian's next earnings date?

United-Guardian is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for United-Guardian
.

How were United-Guardian's earnings last quarter?

United-Guardian, Inc. (NASDAQ:UG) posted its earnings results on Wednesday, May, 12th. The company reported $0.26 earnings per share for the quarter. The business had revenue of $3.43 million for the quarter. United-Guardian had a net margin of 33.32% and a trailing twelve-month return on equity of 33.63%.
View United-Guardian's earnings history
.

How has United-Guardian's stock price been impacted by Coronavirus (COVID-19)?

United-Guardian's stock was trading at $15.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, UG stock has increased by 1.6% and is now trading at $15.45.
View which stocks have been most impacted by COVID-19
.

How often does United-Guardian pay dividends? What is the dividend yield for United-Guardian?

United-Guardian announced a dividend on Thursday, May 20th. Investors of record on Monday, May 31st will be paid a dividend of $0.48 per share on Friday, May 7th. The ex-dividend date is Thursday, May 27th. This is a boost from United-Guardian's previous dividend of $0.35.
View United-Guardian's dividend history
.

Is United-Guardian a good dividend stock?

United-Guardian pays an annual dividend of $0.96 per share and currently has a dividend yield of 6.06%. UG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View United-Guardian's dividend history.

Who are United-Guardian's key executives?

United-Guardian's management team includes the following people:
  • Mr. Kenneth H. Globus, Pres, Gen. Counsel, CEO & Chairman (Age 69, Pay $440.75k)
  • Ms. Andrea J. Young, CFO, Treasurer, Controller, Sec. & HR Mang. (Age 52, Pay $148.57k)
  • Mr. Peter A. Hiltunen, Sr. VP & Production Mang. (Age 62, Pay $217.71k)
  • Ms. Donna Vigilante, VP, R&D Mang. and Director of Technical Services (Age 41)

What is Kenneth H. Globus' approval rating as United-Guardian's CEO?

4 employees have rated United-Guardian CEO Kenneth H. Globus on Glassdoor.com. Kenneth H. Globus has an approval rating of 72% among United-Guardian's employees.

Who are some of United-Guardian's key competitors?

What other stocks do shareholders of United-Guardian own?

Based on aggregate information from My MarketBeat watchlists, some companies that other United-Guardian investors own include Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T), Teekay LNG Partners (TGP), Verizon Communications (VZ), Walgreens Boots Alliance (WBA), Wells Fargo & Company (WFC), Continental Resources (CLR), Cinemark (CNK) and Dominion Energy (D).

What is United-Guardian's stock symbol?

United-Guardian trades on the NASDAQ under the ticker symbol "UG."

How do I buy shares of United-Guardian?

Shares of UG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is United-Guardian's stock price today?

One share of UG stock can currently be purchased for approximately $15.45.

How much money does United-Guardian make?

United-Guardian has a market capitalization of $70.92 million and generates $10.99 million in revenue each year.

How many employees does United-Guardian have?

United-Guardian employs 22 workers across the globe.

What is United-Guardian's official website?

The official website for United-Guardian is www.u-g.com.

Where are United-Guardian's headquarters?

United-Guardian is headquartered at 230 MARCUS BOULEVARD, HAUPPAUGE NY, 11788.

How can I contact United-Guardian?

United-Guardian's mailing address is 230 MARCUS BOULEVARD, HAUPPAUGE NY, 11788. The company can be reached via phone at (631) 273-0900.


This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.